FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225304310> ?p ?o ?g. }

• W4225304310 endingPage "158" @default.
• W4225304310 startingPage "150" @default.
• W4225304310 abstract "The objective of this study was to propose prognostic factors and optimal treatment strategies by analyzing the clinicopathological features and programmed death-ligand 1 (PD-L1) expression. We analyzed 31 patients diagnosed with uterine or ovarian melanoma between 1997 and 2017 in the Kansai Clinical Oncology Group/Intergroup. Twenty-four and seven patients with cervical and ovarian melanomas were included, respectively. Immune checkpoint inhibitors were used in seven patients, and the objective response rate was 40%. Notably, two patients with objective responses had a high PD-L1 expression. Ten and four patients with cervical and ovarian melanomas, respectively, had high PD-L1 immunohistochemical expressions. Multivariate analysis revealed that tumor stage was an independent prognostic factor for progression-free survival in patients with cervical melanomas. In patients with ovarian melanomas, the 1-year cumulative progression-free and overall survival rates were 0 and 29%, respectively. Kaplan–Meier analyses revealed that age <60 years was associated with poorer progression-free and overall survivals in patients with ovarian melanomas. In patients with cervical melanomas, the 1-, 3-, and 5-year cumulative overall survival rates were 53, 32, and 16%, respectively. Histological atypia was associated with a poorer progression-free survival, but there was no difference in survival between patients who underwent radical hysterectomy and those who did not. The present study is a large cohort study of uterine and ovarian melanomas, which are aggressive tumors with a significantly poor prognosis, even after standard surgery and adjuvant therapy. The use of immune checkpoint inhibitors is a promising and effective treatment option." @default.
• W4225304310 created "2022-05-05" @default.
• W4225304310 creator A5002237581 @default.
• W4225304310 creator A5002489205 @default.
• W4225304310 creator A5004432102 @default.
• W4225304310 creator A5007587514 @default.
• W4225304310 creator A5011758390 @default.
• W4225304310 creator A5016566770 @default.
• W4225304310 creator A5017675985 @default.
• W4225304310 creator A5023869784 @default.
• W4225304310 creator A5031915386 @default.
• W4225304310 creator A5033185576 @default.
• W4225304310 creator A5035315695 @default.
• W4225304310 creator A5040182525 @default.
• W4225304310 creator A5048738520 @default.
• W4225304310 creator A5051776814 @default.
• W4225304310 creator A5053051266 @default.
• W4225304310 creator A5055379945 @default.
• W4225304310 creator A5055573382 @default.
• W4225304310 creator A5059587982 @default.
• W4225304310 creator A5062577566 @default.
• W4225304310 creator A5062879016 @default.
• W4225304310 creator A5063430664 @default.
• W4225304310 creator A5064251386 @default.
• W4225304310 creator A5068073511 @default.
• W4225304310 creator A5068895489 @default.
• W4225304310 creator A5069962889 @default.
• W4225304310 creator A5073332474 @default.
• W4225304310 creator A5075597239 @default.
• W4225304310 creator A5076367477 @default.
• W4225304310 date "2022-03-29" @default.
• W4225304310 modified "2023-10-16" @default.
• W4225304310 title "Clinicopathological features and programmed death-ligand 1 immunohistochemical expression in a multicenter cohort of uterine and ovarian melanomas: a retrospective study in Japan (KCOG-G1701s)" @default.
• W4225304310 cites W1972323282 @default.
• W4225304310 cites W1989121777 @default.
• W4225304310 cites W2037117326 @default.
• W4225304310 cites W2066590817 @default.
• W4225304310 cites W2096387850 @default.
• W4225304310 cites W2103152130 @default.
• W4225304310 cites W2128542677 @default.
• W4225304310 cites W2553340100 @default.
• W4225304310 cites W2607342841 @default.
• W4225304310 cites W2668417523 @default.
• W4225304310 cites W2890146531 @default.
• W4225304310 cites W2894584497 @default.
• W4225304310 cites W2895470145 @default.
• W4225304310 cites W2898281840 @default.
• W4225304310 cites W2898394368 @default.
• W4225304310 cites W2981521786 @default.
• W4225304310 cites W3039760251 @default.
• W4225304310 cites W3043703771 @default.
• W4225304310 cites W3086347995 @default.
• W4225304310 cites W3087697977 @default.
• W4225304310 doi "https://doi.org/10.1097/cmr.0000000000000811" @default.
• W4225304310 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35377861" @default.
• W4225304310 hasPublicationYear "2022" @default.
• W4225304310 type Work @default.
• W4225304310 citedByCount "1" @default.
• W4225304310 countsByYear W42253043102023 @default.
• W4225304310 crossrefType "journal-article" @default.
• W4225304310 hasAuthorship W4225304310A5002237581 @default.
• W4225304310 hasAuthorship W4225304310A5002489205 @default.
• W4225304310 hasAuthorship W4225304310A5004432102 @default.
• W4225304310 hasAuthorship W4225304310A5007587514 @default.
• W4225304310 hasAuthorship W4225304310A5011758390 @default.
• W4225304310 hasAuthorship W4225304310A5016566770 @default.
• W4225304310 hasAuthorship W4225304310A5017675985 @default.
• W4225304310 hasAuthorship W4225304310A5023869784 @default.
• W4225304310 hasAuthorship W4225304310A5031915386 @default.
• W4225304310 hasAuthorship W4225304310A5033185576 @default.
• W4225304310 hasAuthorship W4225304310A5035315695 @default.
• W4225304310 hasAuthorship W4225304310A5040182525 @default.
• W4225304310 hasAuthorship W4225304310A5048738520 @default.
• W4225304310 hasAuthorship W4225304310A5051776814 @default.
• W4225304310 hasAuthorship W4225304310A5053051266 @default.
• W4225304310 hasAuthorship W4225304310A5055379945 @default.
• W4225304310 hasAuthorship W4225304310A5055573382 @default.
• W4225304310 hasAuthorship W4225304310A5059587982 @default.
• W4225304310 hasAuthorship W4225304310A5062577566 @default.
• W4225304310 hasAuthorship W4225304310A5062879016 @default.
• W4225304310 hasAuthorship W4225304310A5063430664 @default.
• W4225304310 hasAuthorship W4225304310A5064251386 @default.
• W4225304310 hasAuthorship W4225304310A5068073511 @default.
• W4225304310 hasAuthorship W4225304310A5068895489 @default.
• W4225304310 hasAuthorship W4225304310A5069962889 @default.
• W4225304310 hasAuthorship W4225304310A5073332474 @default.
• W4225304310 hasAuthorship W4225304310A5075597239 @default.
• W4225304310 hasAuthorship W4225304310A5076367477 @default.
• W4225304310 hasConcept C121608353 @default.
• W4225304310 hasConcept C126322002 @default.
• W4225304310 hasConcept C143998085 @default.
• W4225304310 hasConcept C146357865 @default.
• W4225304310 hasConcept C151730666 @default.
• W4225304310 hasConcept C167135981 @default.
• W4225304310 hasConcept C204232928 @default.
• W4225304310 hasConcept C2777658100 @default.
• W4225304310 hasConcept C2777982462 @default.
• W4225304310 hasConcept C2780739268 @default.

• next